Biotechnology Venture Capital Firms
The world of biotechnology is one filled with unlimited potential and opportunities. Built upon transformative innovations that have the strength to redefine industries, it comes as no surprise that it stands as a powerful magnet for venture capital (VC) firms keen on investing in the future. Welcome to VC Firms List, the one-stop destination for all detailed information on biotechnology venture capital firms. As you explore, you will discover why we are the go-to website for anyone seeking insights into the VC firms and investors specializing in the biotechnology sector.
Read more
Company:
JourneyOne Ventures
Description: JourneyOne Ventures is a distinguished early-stage investment fund owned wholly by women and minority stakeholders. This unique venture capital firm is committed to supporting innovative software, biotechnology, and consumer startups that operate within the frontier wellness sectors. The goal of JourneyOne Ventures is to foster businesses that enhance the wellbeing and happiness of individuals. By focusing on impactful investments, the firm is dedicated to making a positive difference in the lives of people through its portfolio companies. For those interested in becoming limited partners, more information can be requested through their contact at investorsjourneyonevc.
Industry: Venture Capital and Private Equity
Founded: 2021
Domain: http://www.journeyone.vc/
Location: Los Angeles, CA
Address: Los Angeles, CA 90029, US
Size: 2-10 employees
Company:
Kinzon Capital
Description: Kinzon Capital is a venture capital and private equity firm dedicated to investing in early-stage and growth-stage companies that are at the forefront of technology innovation. With a strong international technology vision and access to extensive industrial resources, Kinzon Capital is committed to exploring groundbreaking technological advancements while empowering leading entrepreneurs in their endeavors. The firm's investment focus spans various sectors, including Net Zero initiatives, Smart Mobility, the Electric Vehicle value chain, high-end manufacturing, integrated circuits, and biotechnology. Through its strategic approach, Kinzon Capital aims to foster innovation and support the development of transformative technologies that have the potential to shape the future.
Industry: Venture Capital and Private Equity
Founded: 2016
Domain: http://www.kinzoncap.com/
Size: 11-50 employees
Company:
LYZZ CAPITAL
Description: LYZZ Capital is a prominent venture capital and private equity firm that specializes in the healthcare sector. With a robust investment portfolio, the firm is currently managing funds in both USD and RMB, amounting to over USD 460 million. The accomplished team at LYZZ Capital consists of seasoned investment and operating professionals who bring extensive experience from leading pharmaceutical and biotech companies, as well as from reputable Wall Street firms. Their backgrounds encompass strong scientific and medical expertise, ensuring a comprehensive approach to investment strategies.
Having collaborated for over a decade, the LYZZ Capital team has developed a culture that values cordiality, flat hierarchies, and a team-oriented working environment. Their collective experience in biotech investments spans more than 15 years, with over a decade of active engagement in the Chinese market. LYZZ Capital focuses its investments on identifying and supporting talent, assets, and innovative technologies on a global scale. The firm places particular emphasis on addressing unmet medical needs and recognizes the significant market potential within China, aligning their investment strategies with the evolving landscape of global healthcare challenges.
Industry: Venture Capital and Private Equity
Founded: 2014
Domain: http://www.lyzzcap.com/
Location: Shanghai
Address: Shanghai, CN
Size: 11-50 employees
Company:
Life Science Angels
Description: Life Science Angels is recognized as the nation's premier healthcare-focused angel investment organization. The organization has established two dedicated committees that specialize in reviewing medical technology and biotechnology investment opportunities. These committees play a crucial role in the investment process, as they are responsible for selecting companies to present to the broader membership. This selection is based on a rigorous due diligence process designed to ensure the quality and potential of the investment opportunities.
Members of Life Science Angels retain the autonomy to make their own investment decisions, although all investments are facilitated through a single Limited Liability Company (LLC). Typical investment amounts from Life Science Angels range from $200,000 to $600,000, while syndicated financings can extend to as much as $2.3 million. Through its structured approach to investment in the life sciences sector, Life Science Angels continues to foster innovation and support the growth of emerging companies in healthcare.
Industry: Venture Capital and Private Equity
Founded: 2004
Location: Sunnyvale, CA
Address: 1230 Bordeux Drive, Sunnyvale, CA 94089, US
Size: 51-200 employees
Company:
Lifeforce Capital
Description: Lifeforce Capital is a distinguished venture capital and private equity firm dedicated to transforming the landscape of healthcare through innovative technological advancements and novel care models. The firm actively invests in companies that are at the forefront of advancing care delivery, focusing on solutions that leverage cutting-edge technologies to enhance patient outcomes. By emphasizing a shift away from conventional biotechnology approaches, Lifeforce Capital supports the development of software-first computational drug discovery platforms. These platforms represent a significant paradigm shift in the industry, aligning with the firm's mission to foster innovation that enhances efficiency and efficacy in the healthcare sector. Through their strategic investments, Lifeforce Capital plays a vital role in promoting forward-thinking solutions that aim to reshape the future of healthcare.
Industry: Venture Capital and Private Equity
Founded: 2015
Domain: http://www.lifeforcecap.com/
Size: 2-10 employees
Company:
Lightstone Ventures
Description: Lightstone Ventures is a prominent global venture capital fund that is dedicated to converting groundbreaking scientific innovations into therapies that are both clinically and commercially significant. The firm focuses on investing in biotechnology and medical technology companies that are at the forefront of transformative ideas aimed at enhancing patient outcomes. Established in 2012, Lightstone Ventures was founded with the intention of empowering visionary entrepreneurs by providing the essential resources and operational expertise needed to develop and deliver innovative therapeutics and technologies to those who need them the most.
With a robust investment team that has successfully led deals resulting in 19 acquisitions and 20 initial public offerings over the past two decades, Lightstone Ventures has built a substantial track record in the venture capital space. Their offices are strategically located in key global markets, including Boston, Massachusetts, Menlo Park, California, and Dublin, Ireland, allowing them to stay connected with the dynamic landscape of the biotech and medtech industries. To learn more about Lightstone Ventures and their contributions to the field, one can visit their website at www.lightstonevc.com.
Industry: Venture Capital and Private Equity
Founded: 2012
Domain: http://www.lightstonevc.com/
Location: Menlo Park, CA
Address: 2884 Sand Hill Road, Suite 121, Menlo Park, CA, US
Size: 11-50 employees
Company:
LiquidMetal Ventures 观正资本
Description: LiquidMetal Ventures 观正资本 is a venture capital fund based in Boston that specializes in early-stage investments. The firm concentrates on sectors such as energy sustainability, biotechnology, healthcare, and artificial intelligence in robotics. LiquidMetal Ventures is committed to empowering bold and imaginative entrepreneurs as they progress from the Seed stage to Series A funding. By leveraging extensive connections within the Boston startup ecosystem and the global market, the firm aims to provide valuable support and resources to the companies it backs.
The expert team at LiquidMetal Ventures brings years of experience in incubating innovative ideas and guiding entrepreneurs to maximize the benefits of their partnerships with the fund. Their strong relationships with peer venture capital funds provide LiquidMetal Ventures with a distinct advantage in accessing off-the-market, early-stage investment opportunities. This collaborative approach not only enhances their investment portfolio but also plays a significant role in mitigating risks associated with new ventures, thereby fostering growth and innovation within the industries they support.
Industry: Venture Capital and Private Equity
Founded: 2021
Domain: http://www.liquidmetalvc.com/
Location: Boston, Massachusetts
Address: Boston, Massachusetts, US
Size: 11-50 employees
Company:
Longitude Capital
Description: Longitude Capital is a prominent firm specializing in venture growth investments within the biotechnology, medical technology, and health solutions sectors. The firm focuses on identifying and supporting companies that aim to enhance clinical outcomes, improve quality of life, and reduce healthcare system costs. Longitude Capital has a diverse investment strategy, allowing it to invest in both privately held and publicly traded life science companies. Through its commitment to fostering innovation and advancing healthcare solutions, Longitude Capital plays a vital role in the life sciences investment landscape.
Industry: Venture Capital and Private Equity
Founded: 2006
Domain: http://www.longitudecapital.com/
Location: Menlo Park, CA
Address: 2740 Sand Hill Road, 2nd Floor, Menlo Park, CA 94025, US
Size: 11-50 employees
Company:
Lucas Venture Group
Description: Lucas Venture Group is a distinguished boutique venture capital firm situated in Silicon Valley, founded by Donald A. Lucas, who is recognized as a second-generation venture capitalist. The firm is guided by General Partners Sarah Lucas and Jack Lucas, who bring a wealth of knowledge and expertise to the organization. Lucas Venture Group specializes in early-stage investments across a broad spectrum of industries, including artificial intelligence and machine learning (AI & ML), software as a service (SaaS), space technology, financial technology (fintech), social purpose enterprises, consumer packaged goods (CPG), and biotechnology.
With more than sixty years of collective experience in the venture capital sector, Lucas Venture Group has cultivated an extensive network that enables entrepreneurs to access vital financial resources and intellectual capital. The firm adopts a holistic approach to fostering the growth and success of its portfolio companies, offering not only essential financial support but also strategic guidance and operational expertise tailored to each company’s unique needs.
Lucas Venture Group has achieved notable milestones in its journey, with recent exit highlights including successful investments in companies such as Berkeley Lights, Palantir, and Truebill. Through its commitment to nurturing innovative startups, Lucas Venture Group continues to play a significant role in shaping the future of various industries while empowering entrepreneurs to realize their vision.
Industry: Venture Capital and Private Equity
Founded: 1990
Domain: http://www.lucasvg.com/
Location: Palo Alto, California
Address: 555 Bryant St, 239, Palo Alto, California 94301, US
Size: 2-10 employees
Company:
MPM BioImpact
Description: MPM BioImpact stands as a prominent biotechnology investment firm, recognized for its nearly thirty years of experience in creating and investing in companies dedicated to translating scientific innovations into effective cures for significant diseases. With a highly skilled team and extensive expertise in scientific research, clinical development, and company building, MPM BioImpact is committed to driving forward groundbreaking medical advancements that can positively impact patients' lives. The firm engages in investments across the entire biotechnology spectrum, spanning from early-stage startups to established public companies. Through its strategic approach and deep industry knowledge, MPM BioImpact plays a crucial role in fostering the next generation of medical breakthroughs.
Industry: Venture Capital and Private Equity
Domain: http://www.mpmbioimpact.com/
Location: Boston, Massachusetts
Address: 399 Boylston St, Boston, Massachusetts 02116, US
Size: 11-50 employees
Company:
Milestone Capital
Description: Milestone Capital is a distinguished venture capital and private equity firm that manages three US dollar private equity funds, primarily investing in well-established high-growth companies that are seeking expansion or acquisition capital in China. The firm’s objective is to maximize medium to long-term capital appreciation by making direct investments that allow for the acquisition of either minority or majority equity stakes in carefully selected companies. These companies are identified by Milestone Capital's experienced investment team, which is committed to recognizing potential for growth and success.
Milestone Capital boasts a strong track record of assisting portfolio companies in their pursuit of public listings on both domestic and international stock exchanges. By leveraging an extensive network of advisors, industry executives, and established business relationships, the firm provides comprehensive value-added support from both financial and strategic perspectives. This commitment enhances the operational capacities of portfolio companies, allowing them to navigate complex financial landscapes more effectively.
To date, Milestone Capital has successfully facilitated the public listing of ten of its portfolio companies on major overseas stock exchanges. Notably, in July 2005, Focus Media Holdings Limited (Ticker: FMCN) made its debut on the NASDAQ, followed by Trina Solar Limited (Ticker: TSL), which listed on the New York Stock Exchange in December 2006. VisionChina Media Inc. (Ticker: VISN) followed suit with a NASDAQ listing in December 2007. Additionally, GCL Silicon Technology Holdings Inc. became part of GCL-Poly Energy Holdings Limited (Ticker: 3800HK) through acquisition in April 2010. Other successful listings include Dehaier Medical Systems Limited (Ticker: DHRM) on the NASDAQ in July 2012, Xiao Nan Guo Restaurants Holdings Limited (Ticker: 3666HK) on the Hong Kong Stock Exchange (HKSE) in September 2013, and Tenwow International Holdings Limited (Ticker: 1219HK) on the HKSE in October 2013. Milestone Capital also facilitated the listing of Cabbeen Fashion Limited (Ticker: 2030HK) on the HKSE in September 2015 and JHL Biotech (Ticker: 6540TW) on the Emerging Stock Board of Taipei Exchange in June 2017, followed by Aslan Pharmaceuticals (Ticker: 6497), which listed on the Main Board of Taipei Exchange.
Through its strategic investments and support, Milestone Capital continues to solidify its reputation as a leader in the venture capital and private equity space, driving growth and value creation for its portfolio companies within the dynamic landscape of the Asian markets.
Industry: Venture Capital and Private Equity
Founded: 2002
Domain: http://www.mcmchina.com/
Location: 上海市, 上海市
Address: 湖南路, 上海市, 上海市 200031, CN
Size: 11-50 employees
Company:
Mission BioCapital
Description: Mission BioCapital is a distinguished venture capital firm that specializes in making significant early-stage investments within the biotechnology sector. The firm is dedicated to fostering innovation by providing not only financial backing but also vital resources to promising biotech companies. Mission BioCapital offers essential support through access to lab space, capital, and connections to strategic partners, thereby facilitating the growth and development of these companies from their inception to a successful exit. By leveraging its expertise and network, Mission BioCapital plays a crucial role in advancing the biotechnology landscape, ensuring that groundbreaking ideas have the opportunity to thrive and make a lasting impact in the industry.
Industry: Venture Capital and Private Equity
Founded: 2015
Location: Cambridge, Massachusetts
Address: 139 Main St, Suite 401, Cambridge, Massachusetts 02142, US
Size: 11-50 employees
Company:
Monograph Capital
Description: Monograph Capital is a venture capital firm established with the mission of investing in life sciences companies focused on the development of innovative therapeutics, diagnostics, and technology-enabled business services aimed at enhancing healthcare outcomes. The firm operates from its primary offices located in London, San Francisco, and the Dallas-Fort Worth area, allowing it to effectively bridge investment opportunities across North America, the United Kingdom, and Europe.
The team at Monograph Capital comprises professionals with decades of experience in biomedical research and clinical medicine, as well as a collective total of over 55 years of investment experience specifically within the healthcare sector. This extensive background empowers Monograph to play an active role in fostering the growth of emerging organizations, transforming them into successful biotechnology firms and related life sciences businesses.
Monograph Capital is adept at identifying opportunities that have the potential to lead to significant advancements in healthcare outcomes, consistently engaging with innovative companies to support their journey toward scalability and success within the life sciences landscape.
Industry: Venture Capital and Private Equity
Domain: http://www.monograph.bio/
Location: London
Address: London, GB
Size: 11-50 employees
Company:
Next Capital 嘉程资本
Description: Next Capital 嘉程资本 is a technology-focused early-stage fund that recognizes the transformative potential of tech-driven business model innovations. Dedicated to discovering the next big breakthrough, Next Capital aims to collaborate with aspiring business leaders who exhibit high potential for growth and innovation.
The firm invests across a diverse range of sectors, including artificial intelligence, advanced hard technology, digital healthcare and wellness, globalization, biotechnology and life sciences, corporate services, cloud-native applications, software-defined radio infrastructure (SDRI), and robotics. Notable companies within Next Capital's portfolio include Genki Forest, PandaRemit, Finding Unicorn, Shoplazza, XellSmart, Atantares, Veminsyn, GLZHealth, SIBIONICS, and various other pioneering enterprises.
Next Capital 嘉程资本 also offers a comprehensive venture capital service platform that consists of initiatives such as NEXT LEAGUE, NEXT INNOVATION CAMP, and NEXT CLUB. This platform is designed to support Chinese tech innovators across multiple niches, facilitating connections throughout Greater China, North America, Europe, and Singapore. With a network of over 3,000 tech entrepreneurs and senior executives from leading corporations, the platform encourages the exchange of valuable insights and the sharing of emerging trends within the technology sector.
The investment team at Next Capital is composed of professionals with extensive experience drawn from well-known funds and technology giants. They possess a deep understanding of the early-stage investment landscape and have successfully led investments in renowned companies such as Lexin (NASDAQ: LX), Tiger Brokers (NASDAQ: TIGR), Tuanche (NASDAQ: TC), MeetYou, Niuguwang, Hose, PingCAP, Caibeike, Lockin, and other innovative startups during their angel funding rounds. Additionally, the team is credited with founding the respected venture capital service platform, xfzcn.
Next Capital 嘉程资本 positions itself as a supportive partner for innovators, fostering an environment that promotes thought leadership and growth within the rapidly evolving technology sector.
Industry: Venture Capital and Private Equity
Founded: 2017
Domain: http://www.jiachengcap.com/
Location: Beijing, Beijing
Address: Taikang Financial Tower, Beijing, Beijing 100026, CN
Size: 11-50 employees